Gilotrif and Furosemide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gilotrif (afatinib dimaleate) and Furosemide (furosemide). Common drug interactions include cheilitis among females and decreased appetite among males.
The phase IV clinical study analyzes what interactions people have when they take Gilotrif and Furosemide. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.
What is Gilotrif?
Gilotrif has active ingredients of afatinib dimaleate. eHealthMe is studying from 6,055 Gilotrif users. Check the latest studies of Gilotrif.
What is Furosemide?
Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
58 people who take Gilotrif and Furosemide together, and have interactions are studied.

What are the common drug interactions of Gilotrif and Furosemide, by gender? *:
female:
- Cheilitis (infection of lips)
- Cough
- Dry mouth
- Dyspnoea (difficult or laboured respiration)
- Gingival bleeding (bleeding gums)
- Herpes virus infection
- Immunodeficiency
- Nail disorder (disease of nail)
- Neck mass (mass in neck)
- Oral mucosal erythema (redness of the mucous membrane of mouth)
male:
- Decreased appetite
- Diarrhoea
- Diplopia (double vision)
- Eating disorder
- Flatulence (flatus expelled through the anus)
- Gastric ulcer (stomach ulcer)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hypophagia (reduced food intake)
- Intestinal obstruction
What are the common drug interactions of Gilotrif and Furosemide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Diarrhoea
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
40-49:
n/a
50-59:
- Diarrhoea
- Constipation
- Dry eye (lack of adequate tears)
- Dry skin
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Onychoclasis (breaking of the nails)
- Oral herpes (viral infection of mouth)
- Oropharyngeal pain
- Photopsia (presence of perceived flashes of light)
60+:
- Diarrhoea
- Decreased appetite
- Cough
- Lip pain
- Hypophagia (reduced food intake)
- Pain in extremity
- Abdominal distension
- Abdominal pain
- Diplopia (double vision)
- Eating disorder
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 29 people, 50.00%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 11 people, 18.97%
- High Blood Pressure: 11 people, 18.97%
- Lung Neoplasm Malignant (cancer tumour of lung): 9 people, 15.52%
- Diarrhea: 9 people, 15.52%
- Constipation: 7 people, 12.07%
- Cardiac Disorder: 5 people, 8.62%
- Pre-Existing Disease: 4 people, 6.90%
- Fever: 4 people, 6.90%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Gilotrif and Furosemide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gilotrif (6,055 reports)
- Furosemide (316,095 reports)
Browse all drug interactions of Gilotrif and Furosemide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gilotrif:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Furosemide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gilotrif and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Furosemide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
- Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
How the study uses the data?
The study uses data from the FDA. It is based on afatinib dimaleate and furosemide (the active ingredients of Gilotrif and Furosemide, respectively), and Gilotrif and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Valsartan cause Fatigue Aggravated? - now
- Could Opdivo cause Weight Loss? - a second ago
- Could Valsartan cause Hypocalcaemia? - 11 seconds ago
- Could Ondansetron cause Septic Shock? - 15 seconds ago
- Could Onivyde cause Diarrhea? - 15 seconds ago
- Could Onivyde cause Stools - Watery? - 15 seconds ago
- Atenolol and Tacrolimus drug interactions for men aged 50-59 - 17 seconds ago
- Could Cotrim cause Thrombosis? - 18 seconds ago
- Could Azithromycin cause Sleep Disorder? - 21 seconds ago
- Plan B and Prednisone drug interactions for women aged 20-29 - 21 seconds ago